Search research articles
Contact Us
Filters
Showing results (281-290 of 373) with videos related to
Page
of 38
Sort By:
Pediatric Dermatology
|
July 12, 2016
Acne Knowledge of Hispanic Parents of Teenagers with Mild to Moderate Acne
Isha Lopez, Lucio Zapata, Juan Jesús Sosa, et al.
American Journal of Clinical Dermatology
|
May 14, 2025
Correction to: Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study
Amit Garg, Yvonne Geissbühler, Emma Houchen, et al.
American Journal of Clinical Dermatology
|
February 21, 2020
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice
Errol P Prens, Aida M Lugo-Somolinos, Amy S Paller, et al.
JAMA Dermatology
|
December 31, 2014
Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes
Vanessa L Pascoe, Monica Enamandram, Kristen C Corey, et al.
Lancet (London, England)
|
May 20, 2008
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L Leonardi, Alexa B Kimball, Kim A Papp, et al.
International Journal of Women'S Dermatology
|
July 9, 2020
Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
Kevin T Savage, Elena Gonzalez Brant, Monica Rosales Santillan, et al.
NEJM Evidence
|
February 9, 2024
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa
Alexa B Kimball, Elena Peeva, Seth Forman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 24, 2015
HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
A B Kimball, J M Sobell, C C Zouboulis, et al.
Pediatric Dermatology
|
December 24, 2021
Effects of swimming on facial sebum in adolescents
Peyton C Morss-Walton, Ranch Kimball, Monica Rosales Santillan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 3, 2013
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
A B Kimball, K A Papp, Y Wasfi, et al.
Page
of 38
Search research articles
Search
Showing results (281-290 of 373) with videos related to
Sort By:
Page
of 38
Pediatric Dermatology
|
July 12, 2016
Acne Knowledge of Hispanic Parents of Teenagers with Mild to Moderate Acne
Isha Lopez, Lucio Zapata, Juan Jesús Sosa, et al.
American Journal of Clinical Dermatology
|
May 14, 2025
Correction to: Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study
Amit Garg, Yvonne Geissbühler, Emma Houchen, et al.
American Journal of Clinical Dermatology
|
February 21, 2020
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice
Errol P Prens, Aida M Lugo-Somolinos, Amy S Paller, et al.
JAMA Dermatology
|
December 31, 2014
Using the Physician Global Assessment in a clinical setting to measure and track patient outcomes
Vanessa L Pascoe, Monica Enamandram, Kristen C Corey, et al.
Lancet (London, England)
|
May 20, 2008
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L Leonardi, Alexa B Kimball, Kim A Papp, et al.
International Journal of Women'S Dermatology
|
July 9, 2020
Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
Kevin T Savage, Elena Gonzalez Brant, Monica Rosales Santillan, et al.
NEJM Evidence
|
February 9, 2024
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa
Alexa B Kimball, Elena Peeva, Seth Forman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 24, 2015
HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
A B Kimball, J M Sobell, C C Zouboulis, et al.
Pediatric Dermatology
|
December 24, 2021
Effects of swimming on facial sebum in adolescents
Peyton C Morss-Walton, Ranch Kimball, Monica Rosales Santillan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 3, 2013
Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study
A B Kimball, K A Papp, Y Wasfi, et al.
Page
of 38